Remote hearing checks could save cancer Patients' hearing

NCT ID NCT06662058

First seen Apr 23, 2026 · Last updated Apr 28, 2026 · Updated 1 time

Summary

This study looks at whether offering hearing tests close to home or remotely helps more head and neck cancer patients get their hearing checked during treatment. Many patients on cisplatin chemotherapy or radiation near the ear can lose hearing, but regular monitoring can catch changes early. The study will enroll 118 adults with head and neck cancer to see if remote testing boosts participation in hearing checks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory Midtown University Hospital/Winship Cancer Institute

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

CLINICAL STAGE IV HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY HEAD AND NECK SQUAMOUS CELL CARCINOMA HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA LARYNGEAL SQUAMOUS CELL CARCINOMA METASTATIC CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA METASTATIC HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA METASTATIC LARYNGEAL SQUAMOUS CELL CARCINOMA METASTATIC NASOPHARYNGEAL SQUAMOUS CELL CARCINOMA METASTATIC ORAL CAVITY SQUAMOUS CELL CARCINOMA METASTATIC OROPHARYNGEAL SQUAMOUS CELL CARCINOMA METASTATIC PARANASAL SINUS SQUAMOUS CELL CARCINOMA NASOPHARYNGEAL SQUAMOUS CELL CARCINOMA ORAL CAVITY SQUAMOUS CELL CARCINOMA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA PARANASAL SINUS SQUAMOUS CELL CARCINOMA RECURRENT CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA RECURRENT HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA RECURRENT LARYNGEAL SQUAMOUS CELL CARCINOMA RECURRENT NASOPHARYNGEAL SQUAMOUS CELL CARCINOMA RECURRENT ORAL CAVITY SQUAMOUS CELL CARCINOMA RECURRENT OROPHARYNGEAL SQUAMOUS CELL CARCINOMA RECURRENT PARANASAL SINUS SQUAMOUS CELL CARCINOMA STAGE IV CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK AJCC V8 STAGE IV HYPOPHARYNGEAL CARCINOMA AJCC V8 STAGE IV LARYNGEAL CANCER AJCC V8 STAGE IV LIP AND ORAL CAVITY CANCER AJCC V8 STAGE IV NASOPHARYNGEAL CARCINOMA AJCC V8 STAGE IV OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8 STAGE IV SINONASAL CANCER AJCC V8